Tony Pateman

462 total citations
6 papers, 392 citations indexed

About

Tony Pateman is a scholar working on Pharmacology, Immunology and Hepatology. According to data from OpenAlex, Tony Pateman has authored 6 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Pharmacology, 2 papers in Immunology and 2 papers in Hepatology. Recurrent topics in Tony Pateman's work include Hepatitis C virus research (2 papers), Pharmacogenetics and Drug Metabolism (2 papers) and Adenosine and Purinergic Signaling (1 paper). Tony Pateman is often cited by papers focused on Hepatitis C virus research (2 papers), Pharmacogenetics and Drug Metabolism (2 papers) and Adenosine and Purinergic Signaling (1 paper). Tony Pateman collaborates with scholars based in United Kingdom, Netherlands and Ireland. Tony Pateman's co-authors include Martin K. Bayliss, Peter C. Cherry, Peter D. Howes, Andrew Merritt, Darren V. S. Green, Richard C. Bethell, Peter J. Morley, Paul W. Smith, Andrew R. Whittington and Alan Beresford and has published in prestigious journals such as Journal of Medicinal Chemistry, Organic Letters and Drug Discovery Today.

In The Last Decade

Tony Pateman

6 papers receiving 378 citations

Peers

Tony Pateman
John W. Butcher United States
Thomas W. Hudyma United States
Gordon G. Weingarten United Kingdom
Eric P. Seest United States
Oscar Belda Sweden
Mark J. Tebbe United States
Patrick DeRoy Canada
Janet C. Lynn United States
Dmitry V. Kravchenko Russia
Jason D. Burch Canada
John W. Butcher United States
Tony Pateman
Citations per year, relative to Tony Pateman Tony Pateman (= 1×) peers John W. Butcher

Countries citing papers authored by Tony Pateman

Since Specialization
Citations

This map shows the geographic impact of Tony Pateman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tony Pateman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tony Pateman more than expected).

Fields of papers citing papers by Tony Pateman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tony Pateman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tony Pateman. The network helps show where Tony Pateman may publish in the future.

Co-authorship network of co-authors of Tony Pateman

This figure shows the co-authorship network connecting the top 25 collaborators of Tony Pateman. A scholar is included among the top collaborators of Tony Pateman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tony Pateman. Tony Pateman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Andrews, David, Martin R. Johnson, Paul S. Jones, et al.. (2003). The design of potent, non-peptidic inhibitors of hepatitis C protease. European Journal of Medicinal Chemistry. 38(4). 339–343. 12 indexed citations
2.
Schaddelee, Marloes, Erica W. van Tilburg, Tony Pateman, et al.. (2003). Functional role of adenosine receptor subtypes in the regulation of blood–brain barrier permeability: possible implications for the design of synthetic adenosine derivatives. European Journal of Pharmaceutical Sciences. 19(1). 13–22. 29 indexed citations
3.
Andrews, David, Martin R. Johnson, Paul S. Jones, et al.. (2003). Pyrrolidine-5,5-trans-lactams. 5. Pharmacokinetic Optimization of Inhibitors of Hepatitis C Virus NS3/4A Protease. Organic Letters. 5(24). 4631–4634. 19 indexed citations
4.
Pateman, Tony & Martin K. Bayliss. (2002). Pharmacokinetics and Metabolism in Drug Design. Drug Discovery Today. 7(10). 554–554. 12 indexed citations
5.
Pateman, Tony & Martin K. Bayliss. (2001). Pharmacokinetic Optimization in Drug Research. Drug Discovery Today. 6(15). 778–778. 26 indexed citations
6.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John W. Butcher Breakdown of academic impact, for papers by Thomas W. Hudyma Breakdown of academic impact, for papers by Gordon G. Weingarten Breakdown of academic impact, for papers by Eric P. Seest Breakdown of academic impact, for papers by Oscar Belda Breakdown of academic impact, for papers by Mark J. Tebbe Breakdown of academic impact, for papers by Patrick DeRoy Breakdown of academic impact, for papers by Janet C. Lynn Breakdown of academic impact, for papers by Dmitry V. Kravchenko Breakdown of academic impact, for papers by Jason D. Burch
Rankless by CCL
2026